Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1448092
PUBLISHER: KBV Research | PRODUCT CODE: 1448092
LAMEA Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030
PUBLISHED:
PAGES: 128 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Latin America, Middle East and Africa Androgenetic Alopecia Market would witness market growth of 13.1% CAGR during the forecast period (2023-2030).
The Brazil market dominated the LAMEA Androgenetic Alopecia Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $91.5 Million by 2030. The Argentina market is exhibiting a CAGR of 13.7% during (2023 - 2030). Additionally, The UAE market would experience a CAGR of 12.7% during (2023 - 2030).
Research into the regenerative properties of stem cells is gaining momentum. Stem cell therapies stimulate hair follicle growth and represent a potential breakthrough in treating androgenetic alopecia. Cytokines, signaling molecules involved in cell communication, are being explored for their potential role in promoting hair growth. This emerging therapy is under investigation for its ability to modulate hair follicle activity. Nanotechnology is being employed to enhance the delivery of topical treatments. Nanoencapsulation allows for improved absorption of active ingredients, potentially increasing the effectiveness of topical solutions in promoting hair growth.
Wearable devices designed to monitor scalp conditions and hair health are emerging. These devices may provide real-time data on factors influencing hair loss, allowing for proactive intervention and personalized care. Telemedicine is becoming more prevalent in the market, allowing patients to consult with healthcare professionals remotely. Additionally, remote monitoring devices enable ongoing assessment of treatment progress. The revolutionary CRISPR gene-editing technology is being explored for potential applications in correcting genetic factors contributing to androgenetic alopecia. While in the early stages of research, gene therapies hold promise for addressing the root causes of hair loss.
The evolving healthcare landscape in Saudi Arabia includes a shift toward more accessible and personalized care, focusing on home-based solutions. Consumers in Saudi Arabia increasingly prefer convenient and private healthcare options. Telehealth services and virtual consultations allow individuals in Saudi Arabia to connect with healthcare professionals remotely. Homecare settings allow for the customization of androgenetic alopecia solutions to suit diverse populations in Saudi Arabia. As per the International Trade Administration, in 2023, it spent $50.4 billion on healthcare and social development, 16.96 percent of its 2023 budget, and the second largest line item was education. Thus, due to these aspects, the market will expand across the LAMEA region in upcoming years.
Based on Treatment, the market is segmented into Pharmaceuticals, and Devices. Based on Gender, the market is segmented into Male, and Female. Based on Sales Channel, the market is segmented into Prescriptions, and OTC. Based on End-use, the market is segmented into Dermatology Clinics, and Homecare Settings. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Cipla Limited
- Merck & Co., Inc.
- GlaxoSmithKline PLC (GSK)
- Sun Pharmaceuticals Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
- Aurobindo Pharma Limited
- Pfizer, Inc.
- Lutronic Co., Ltd.
- Viatris Inc.
- Eli Lilly and Company
LAMEA Androgenetic Alopecia Market Report Segmentation
By Treatment
- Pharmaceuticals
- Devices
By Gender
- Male
- Female
By Sales Channel
- Prescriptions
- OTC
By End-use
- Dermatology Clinics
- Homecare Settings
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1LAMEA Androgenetic Alopecia Market, by Treatment
- 1.4.2LAMEA Androgenetic Alopecia Market, by Gender
- 1.4.3LAMEA Androgenetic Alopecia Market, by Sales Channel
- 1.4.4LAMEA Androgenetic Alopecia Market, by End-use
- 1.4.5LAMEA Androgenetic Alopecia Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
- 3.3Porter Five Forces Analysis
Chapter 4.LAMEA Androgenetic Alopecia Market, By Treatment
- 4.1LAMEA Pharmaceuticals Market, By Country
- 4.2LAMEA Devices Market, By Country
Chapter 5.LAMEA Androgenetic Alopecia Market, By Gender
- 5.1LAMEA Male Market, By Country
- 5.2LAMEA Female Market, By Country
Chapter 6.LAMEA Androgenetic Alopecia Market, By Sales Channel
- 6.1LAMEA Prescriptions Market, By Country
- 6.2LAMEA OTC Market, By Country
Chapter 7.LAMEA Androgenetic Alopecia Market, By End-use
- 7.1LAMEA Dermatology Clinics Market, By Country
- 7.2LAMEA Homecare Settings Market, By Country
Chapter 8.LAMEA Androgenetic Alopecia Market, By Country
- 8.1Brazil Androgenetic Alopecia Market
- 8.1.1Brazil Androgenetic Alopecia Market, By Treatment
- 8.1.2Brazil Androgenetic Alopecia Market, By Gender
- 8.1.3Brazil Androgenetic Alopecia Market, By Sales Channel
- 8.1.4Brazil Androgenetic Alopecia Market, By End-use
- 8.2Argentina Androgenetic Alopecia Market
- 8.2.1Argentina Androgenetic Alopecia Market, By Treatment
- 8.2.2Argentina Androgenetic Alopecia Market, By Gender
- 8.2.3Argentina Androgenetic Alopecia Market, By Sales Channel
- 8.2.4Argentina Androgenetic Alopecia Market, By End-use
- 8.3UAE Androgenetic Alopecia Market
- 8.3.1UAE Androgenetic Alopecia Market, By Treatment
- 8.3.2UAE Androgenetic Alopecia Market, By Gender
- 8.3.3UAE Androgenetic Alopecia Market, By Sales Channel
- 8.3.4UAE Androgenetic Alopecia Market, By End-use
- 8.4Saudi Arabia Androgenetic Alopecia Market
- 8.4.1Saudi Arabia Androgenetic Alopecia Market, By Treatment
- 8.4.2Saudi Arabia Androgenetic Alopecia Market, By Gender
- 8.4.3Saudi Arabia Androgenetic Alopecia Market, By Sales Channel
- 8.4.4Saudi Arabia Androgenetic Alopecia Market, By End-use
- 8.5South Africa Androgenetic Alopecia Market
- 8.5.1South Africa Androgenetic Alopecia Market, By Treatment
- 8.5.2South Africa Androgenetic Alopecia Market, By Gender
- 8.5.3South Africa Androgenetic Alopecia Market, By Sales Channel
- 8.5.4South Africa Androgenetic Alopecia Market, By End-use
- 8.6Nigeria Androgenetic Alopecia Market
- 8.6.1Nigeria Androgenetic Alopecia Market, By Treatment
- 8.6.2Nigeria Androgenetic Alopecia Market, By Gender
- 8.6.3Nigeria Androgenetic Alopecia Market, By Sales Channel
- 8.6.4Nigeria Androgenetic Alopecia Market, By End-use
- 8.7Rest of LAMEA Androgenetic Alopecia Market
- 8.7.1Rest of LAMEA Androgenetic Alopecia Market, By Treatment
- 8.7.2Rest of LAMEA Androgenetic Alopecia Market, By Gender
- 8.7.3Rest of LAMEA Androgenetic Alopecia Market, By Sales Channel
- 8.7.4Rest of LAMEA Androgenetic Alopecia Market, By End-use
Chapter 9.Company Profiles
- 9.1Cipla Limited
- 9.1.1Company Overview
- 9.1.2Financial Analysis
- 9.1.3Segmental and Regional Analysis
- 9.1.4Research & Development Expense
- 9.1.5SWOT Analysis
- 9.2Merck & Co., Inc.
- 9.2.1Company Overview
- 9.2.2Financial Analysis
- 9.2.3Segmental and Regional Analysis
- 9.2.4Research & Development Expenses
- 9.2.5SWOT Analysis
- 9.3GlaxoSmithKline PLC (GSK)
- 9.3.1Company Overview
- 9.3.2Financial Analysis
- 9.3.3Regional Analysis
- 9.3.4Research & Development Expense
- 9.3.5SWOT Analysis
- 9.4Sun Pharmaceuticals Industries Ltd.
- 9.4.1Company Overview
- 9.4.2Financial Analysis
- 9.4.3Regional Analysis
- 9.4.4Research & Development Expenses
- 9.4.5SWOT Analysis
- 9.5Dr. Reddy's Laboratories Ltd.
- 9.5.1Company Overview
- 9.5.2Financial Analysis
- 9.5.3Segmental and Regional Analysis
- 9.5.4Research & Development Expense
- 9.5.5Recent strategies and developments:
- 9.5.5.1Product Launches and Product Expansions:
- 9.5.6SWOT Analysis
- 9.6Aurobindo Pharma Limited
- 9.6.1Company Overview
- 9.6.2Financial Analysis
- 9.6.3Regional Analysis
- 9.6.4Research & Development Expense
- 9.6.5SWOT Analysis
- 9.7Pfizer, Inc.
- 9.7.1Company Overview
- 9.7.2Financial Analysis
- 9.7.3Regional & Segmental Analysis
- 9.7.4Research & Development Expense
- 9.7.5Recent strategies and developments:
- 9.7.5.1Trails and Approvals:
- 9.7.6SWOT Analysis
- 9.8Lutronic Co., Ltd.
- 9.8.1Company Overview
- 9.8.2Financial Analysis
- 9.8.3Regional Analysis
- 9.8.4Research & Development Expenses
- 9.8.5SWOT Analysis
- 9.9Viatris, Inc.
- 9.9.1Company Overview
- 9.9.2Financial Analysis
- 9.9.3Segmental Analysis
- 9.9.4Research & Development Expense
- 9.9.5SWOT Analysis
- 9.10.Eli Lilly And Company
- 9.10.1Company Overview
- 9.10.2Financial Analysis
- 9.10.3Regional Analysis
- 9.10.4Research & Development Expenses
- 9.10.5SWOT Analysis
LIST OF TABLES
- TABLE 1LAMEA Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 2LAMEA Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 3LAMEA Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 4LAMEA Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 5LAMEA Pharmaceuticals Market, By Country, 2019 - 2022, USD Million
- TABLE 6LAMEA Pharmaceuticals Market, By Country, 2023 - 2030, USD Million
- TABLE 7LAMEA Devices Market, By Country, 2019 - 2022, USD Million
- TABLE 8LAMEA Devices Market, By Country, 2023 - 2030, USD Million
- TABLE 9LAMEA Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 10LAMEA Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 11LAMEA Male Market, By Country, 2019 - 2022, USD Million
- TABLE 12LAMEA Male Market, By Country, 2023 - 2030, USD Million
- TABLE 13LAMEA Female Market, By Country, 2019 - 2022, USD Million
- TABLE 14LAMEA Female Market, By Country, 2023 - 2030, USD Million
- TABLE 15LAMEA Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 16LAMEA Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 17LAMEA Prescriptions Market, By Country, 2019 - 2022, USD Million
- TABLE 18LAMEA Prescriptions Market, By Country, 2023 - 2030, USD Million
- TABLE 19LAMEA OTC Market, By Country, 2019 - 2022, USD Million
- TABLE 20LAMEA OTC Market, By Country, 2023 - 2030, USD Million
- TABLE 21LAMEA Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 22LAMEA Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 23LAMEA Dermatology Clinics Market, By Country, 2019 - 2022, USD Million
- TABLE 24LAMEA Dermatology Clinics Market, By Country, 2023 - 2030, USD Million
- TABLE 25LAMEA Homecare Settings Market, By Country, 2019 - 2022, USD Million
- TABLE 26LAMEA Homecare Settings Market, By Country, 2023 - 2030, USD Million
- TABLE 27LAMEA Androgenetic Alopecia Market, By Country, 2019 - 2022, USD Million
- TABLE 28LAMEA Androgenetic Alopecia Market, By Country, 2023 - 2030, USD Million
- TABLE 29Brazil Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 30Brazil Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 31Brazil Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 32Brazil Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 33Brazil Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 34Brazil Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 35Brazil Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 36Brazil Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 37Brazil Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 38Brazil Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 39Argentina Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 40Argentina Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 41Argentina Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 42Argentina Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 43Argentina Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 44Argentina Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 45Argentina Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 46Argentina Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 47Argentina Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 48Argentina Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 49UAE Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 50UAE Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 51UAE Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 52UAE Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 53UAE Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 54UAE Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 55UAE Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 56UAE Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 57UAE Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 58UAE Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 59Saudi Arabia Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 60Saudi Arabia Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 61Saudi Arabia Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 62Saudi Arabia Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 63Saudi Arabia Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 64Saudi Arabia Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 65Saudi Arabia Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 66Saudi Arabia Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 67Saudi Arabia Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 68Saudi Arabia Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 69South Africa Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 70South Africa Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 71South Africa Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 72South Africa Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 73South Africa Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 74South Africa Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 75South Africa Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 76South Africa Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 77South Africa Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 78South Africa Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 79Nigeria Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 80Nigeria Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 81Nigeria Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 82Nigeria Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 83Nigeria Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 84Nigeria Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 85Nigeria Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 86Nigeria Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 87Nigeria Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 88Nigeria Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 89Rest of LAMEA Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 90Rest of LAMEA Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 91Rest of LAMEA Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 92Rest of LAMEA Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 93Rest of LAMEA Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 94Rest of LAMEA Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 95Rest of LAMEA Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 96Rest of LAMEA Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 97Rest of LAMEA Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 98Rest of LAMEA Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 99Key Information - Cipla Limited
- TABLE 100Key Information - Merck & Co., Inc.
- TABLE 101Key Information - GlaxoSmithKline PLC
- TABLE 102Key Information - Sun Pharmaceuticals Industries Ltd.
- TABLE 103Key Information - Dr. Reddy's Laboratories Ltd.
- TABLE 104key information - Aurobindo Pharma Limited
- TABLE 105Key Information - Pfizer, Inc.
- TABLE 106Key Information - lUTRONIC cO., lTD.
- TABLE 107key information - Viatris, Inc.
- TABLE 108Key Information - Eli Lilly And Company
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.